Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 January 2019 | Story Mamosa Makaya | Photo Xolisa Mnukwa
Nkahiseng
Nkahiseng Ralepeli will join the Rhodes Scholarship cohort of 2019.

Aspiring lawyer and political prodigy, Nkahiseng Ralepeli, will soon join a cohort of Rhodes Scholarship recipients at the University of Oxford in the UK later this year. He completed his LLB at the University of the Free State (UFS) in 2018, and it comes as no surprise that this young achiever has his eyes set on greater heights.

As a student, Nkahiseng was always a cut above the rest, with his involvement in non-governmental organisations such as Corruption Watch and Debate Afrika, where he used debating to not only educate youth in South Africa but to engage various social ills that plague the country in whichever way he could. He represented the UFS at various debating tournaments such as the Pan-African Universities Debating Championships and the World Universities Debating Championships.

“This is something I’ve wanted for an incredibly long time. Receiving this scholarship is so important, and makes me feel that all my efforts and work have been validated. What I’ve learned is that regardless of the situation you’re born into, rich or poor, hard work is rewarded. I hope this experience will help me realise my dreams and career goals, but most importantly I want to have a significant impact in whatever space I find myself in and on the people I encounter,” said Nkahiseng.

As an Abe Bailey Bursary recipient, he is deeply interested in the transformation of African political theory and the establishment of various structures in the development and maintenance of African ‘infant’ democracies and post-civil wars. He later hopes to pursue a career in South African politics. His list of achievements keeps getting longer as he adds to it the Rhodes Scholarship. The UFS is truly proud to have an alumnus of this high calibre.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept